Embecta Corp. (EMBC)
USD 11.3
(-0.35%)
USD 11.3
(-0.35%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 221.5 Million USD | -28.46% |
| 2022 | 309.6 Million USD | -37.07% |
| 2021 | 492 Million USD | 1.13% |
| 2020 | 486.5 Million USD | -3.09% |
| 2019 | 502 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 81.7 Million USD | -22.14% |
| 2024 Q1 | 45.5 Million USD | 76.36% |
| 2024 Q2 | 71.8 Million USD | 57.8% |
| 2023 Q4 | 25.8 Million USD | -49.71% |
| 2023 FY | 221.5 Million USD | -28.46% |
| 2023 Q3 | 51.3 Million USD | -7.73% |
| 2023 Q2 | 55.6 Million USD | -37.39% |
| 2023 Q1 | 88.8 Million USD | 3060.0% |
| 2022 Q1 | 116.6 Million USD | -0.51% |
| 2022 FY | 309.6 Million USD | -37.07% |
| 2022 Q4 | -3 Million USD | -103.09% |
| 2022 Q3 | 97.1 Million USD | -1.82% |
| 2022 Q2 | 98.9 Million USD | -15.18% |
| 2021 Q1 | 124.1 Million USD | 0.0% |
| 2021 Q4 | 117.2 Million USD | -5.71% |
| 2021 Q3 | 124.3 Million USD | -1.66% |
| 2021 FY | 492 Million USD | 1.13% |
| 2021 Q2 | 126.4 Million USD | 1.85% |
| 2020 FY | 486.5 Million USD | -3.09% |
| 2019 FY | 502 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | -32.666% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | 8906.397% |
| Pacira BioSciences, Inc. | 87.67 Million USD | -152.638% |
| PainReform Ltd. | -9.58 Million USD | 2411.144% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 4728.76% |
| SCYNEXIS, Inc. | 72.66 Million USD | -204.807% |
| Journey Medical Corporation | -2.07 Million USD | 10784.998% |
| Safety Shot Inc | -12.18 Million USD | 1917.935% |
| Alpha Teknova, Inc. | -35.56 Million USD | 722.838% |
| Bright Green Corporation | -8.89 Million USD | 2591.177% |
| Procaps Group, S.A. | 38.97 Million USD | -468.342% |
| Alvotech | -354.86 Million USD | 162.419% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | -371.568% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 1566.693% |
| Cosmos Health Inc. | -21.83 Million USD | 1114.602% |
| Dynavax Technologies Corporation | -37.02 Million USD | 698.196% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 242.386% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 238.975% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 4728.76% |
| Theratechnologies Inc. | -10.62 Million USD | 2184.314% |
| Harrow Health, Inc. | 580 Thousand USD | -38089.655% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | 4811.763% |
| Biofrontera Inc. | -22.67 Million USD | 1076.761% |
| DURECT Corporation | -36.88 Million USD | 700.531% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | 4303.834% |
| Cronos Group Inc. | -81.37 Million USD | 372.195% |
| OptiNose, Inc. | -22.74 Million USD | 1073.712% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | -5.963% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 665.729% |
| RedHill Biopharma Ltd. | 12.63 Million USD | -1653.483% |
| Organogenesis Holdings Inc. | 12.52 Million USD | -1668.463% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | 5208.021% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | 3666.357% |
| Radius Health, Inc. | -3.92 Million USD | 5743.312% |
| Universe Pharmaceuticals INC | -3.52 Million USD | 6380.527% |
| ProPhase Labs, Inc. | -21.61 Million USD | 1124.846% |
| Phibro Animal Health Corporation | 53.31 Million USD | -315.455% |
| Procaps Group S.A. | 52.32 Million USD | -323.324% |
| TherapeuticsMD, Inc. | -8.52 Million USD | 2698.85% |
| Viatris Inc. | 766.2 Million USD | 71.091% |
| Rockwell Medical, Inc. | -6.67 Million USD | 3420.84% |
| Aytu BioPharma, Inc. | -5.25 Million USD | 4315.836% |
| SIGA Technologies, Inc. | 83.62 Million USD | -164.885% |
| Tilray Brands, Inc. | -174.74 Million USD | 226.756% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | -2273.808% |
| Shineco, Inc. | -17.06 Million USD | 1397.912% |
| PetIQ, Inc. | 60.01 Million USD | -269.074% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | 4776.226% |
| Incannex Healthcare Limited | -30.04 Million USD | 837.326% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 11.718% |
| Alimera Sciences, Inc. | -1.47 Million USD | 15157.784% |
| Silver Spike Investment Corp. | 7.34 Million USD | -2917.666% |
| Assertio Holdings, Inc. | -243.53 Million USD | 190.952% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | 3859.092% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 1726.6% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | 1520.418% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 1204.735% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 260.683% |
| Hempacco Co., Inc. | -8.81 Million USD | 2613.538% |
| Talphera, Inc. | -16.88 Million USD | 1411.505% |
| Alvotech | -354.86 Million USD | 162.419% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | -314.375% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 39.255% |
| Currenc Group, Inc. | -6.64 Million USD | 3432.94% |
| Kamada Ltd. | 10.06 Million USD | -2100.914% |
| Indivior PLC | -4 Million USD | 5637.5% |
| Evoke Pharma, Inc. | -7.43 Million USD | 3080.8% |
| Flora Growth Corp. | -50.35 Million USD | 539.886% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 1204.735% |
| Evolus, Inc. | -49.23 Million USD | 549.901% |
| HUTCHMED (China) Limited | 18.37 Million USD | -1105.442% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | -12.444% |
| Akanda Corp. | -10.05 Million USD | 2303.679% |